OFFICIAL ACTION INDICATED

USFDA classifies Zydus Lifesciences Jarod unit as 'official action indicated'

The US Food and Drug Administration (USFDA) conducted inspection at the injectables manufacturing facility between April 15 and April 23, 2024, Zydus Lifesciences said in a regulatory filing.

More in OFFICIAL ACTION INDICATED

Torrent Pharma gets warning letter from USFDA for Gujarat facility

The company does not believe that the warning letter will have an impact of disruption of supplies or the existing revenues from operations of this facility, the pharma company said.
Lupin's Goa facility may face regulatory action, says USFDA

"The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed," it added.
USFDA retains OAI status for Indoco's Goa plant

The facility was inspected by the USFDA in January 2019.
USFDA classifies Lupin's Somerset facility as 'Official Action Indicated'

'Official Action Indicated', means approvals of pending applications or supplements from this site maybe withheld.